Charlie Gard '˜not suffering' as parents praise global support
Connie Yates said support from the Pope and US president Donald Trump, as well as medics in America and the Vatican, had given the 11-month-old more time after his life-support was due to be switched off on Friday.
Ms Yates also made a direct plea to Prime Minister Theresa May ahead of her appearance alongside Mr Trump at the G20 summit in Germany, telling LBC: “Support us like others are supporting us.”
His parents want to take him for experimental therapy in the US but lost a lengthy legal battle after judges ruled in favour of doctors at Great Ormond Street Hospital (GOSH), where Charlie is being treated.
Ms Yates said seeing him stricken in hospital and wondering when his last moment would be was “absolute living hell”.
She told Good Morning Britain: “He’s our own flesh and blood and we don’t even have a say in his life whatsoever.
“We are not bad parents, we are there for him all the time, we are completely devoted to him and he’s not in pain and suffering, and I promise everyone I would not sit there and watch my son in pain and suffering, I couldn’t do it.”
Ms Yates said the Pope’s intervention came after she wrote a letter to him, although she did not receive a reply directly, but she did not write to Mr Trump.
She said: “It does give us a hope definitely, because there was no hope left. Charlie was going to die on Friday and, you saw the video we did, we were absolutely devastated.
“We had no control over it, the way it was done.
“And then it was going to be on the Monday instead but then I think the White House got involved over the weekend and then that changed things.”
Charlie is suffering from a rare genetic condition and has brain damage and no-one can be certain whether or not he feels pain, GOSH has said.
Successive legal attempts by Charlie’s parents failed as judges in the High Court, Court of Appeal and Supreme Court in London ruled in favour of GOSH doctors, while the European Court of Human Rights declined to hear the couple’s appeal.
Ms Yates said five doctors, including two in England, thought the experimental treatment could help her son and 18 patients were being treated with the medication.
A US hospital, which cannot be named for legal reasons, has offered to ship the drug to the UK to help Charlie and Ms Yates said this had been offered as early as last December.
The hospital issued a statement on Friday saying it would take the boy in if “legal hurdles” could be cleared or send the medication to GOSH pending approval from government regulator the Food and Drug Administration (FDA).
In his ruling, High Court judge Mr Justice Francis said the couple had, understandably, grasped at the possibility that the therapy might be ‘’pioneering treatment’’.
But he said it had never been tried on a patient with Charlie’s rare form of mitochondrial disease, there was “no evidence” it could help him, and testing it on him would be “unknown territory”.
Charlie can only breathe through a ventilator, cannot move his arms and legs and the therapy is not a cure.
Ms Yates said she had researched Charlie’s rare mitochondrial condition “non-stop” and been told there was a chance it could help Charlie, although GOSH medics argued it would not.
Charlie’s parents will meet doctors at GOSH after they sent a letter outlining what Ms Yates said was “new information” on the nucleoside treatment they are seeking for their son.
She said: “I’ve heard from doctors that there’s around a 10% chance of this working for Charlie so I think that’s a good enough chance to take.
“It’s in his best interests to have a chance at life.”
Ms Yates and Charlie’s father, Chris Gard, both in their 30s and from Bedfont, west London, have been at his bedside since he was admitted to GOSH last October and they recently gave him his first haircut.
Ms Yates said: “I got to keep his hair as well, just those little things that I keep.
“It sounds ridiculous but when I cut his nails I keep the little clippings in case it’s the last time I cut them.”